• Cellvizio®
    • Overview
    • Education
    • Economics
    • Indications
      • Gastroenterology
        • Barrett’s Esophagus
        • Pancreatic Cysts
        • Gastric Disease
        • Inflammatory Bowel Diseases
        • Irritable Bowel Syndrome – Food Intolerance
        • Bilio-Pancreatic Strictures
        • Colorectal Lesions
      • Pulmonology
        • Lung Nodules
        • Lung Transplant
      • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial Network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • US
    • INT
    • FR

Mauna Kea Technologies reports second quarter 2016 sales

by Zina | Jul 12, 2016 | News

Click to read more

New Cellvizio order placed by UGAP for Rouen university hospital

by Zina | Jun 30, 2016 | News

Second Cellvizio order by France's largest hospital purchasing group (UGAP) Mauna Kea Technologies announced that is has received today a second order for a Cellvizio endomicroscopy system from Union des Groupements d'Achat Public...

Mauna Kea Technologies receives U.S. FDA clearance for its near-infrared surgical miniprobes

by Zina | May 25, 2016 | News

Click to read more

Mauna Kea Technologies appoints Pierre Forest as Chief Operating Officer

by Zina | May 17, 2016 | News

Click to read more

Mauna Kea Technologies Cellvizio featured prominently at 2016 World Congress for Bronchology and Interventional Pulmonology

by Zina | May 11, 2016 | News

Click to read the complete PR
« Older Entries
Next Entries »

Articles récents

  • Mauna Kea Technologies Congratulates Stanford Health Care on Completing 100 Food Intolerance Cases with Cellvizio 
  • United European Gastroenterology (UEG) Week 2025 Berlin, Germany
  • American Foregut Society (AFS) Annual Meeting, Dallas, TX
  • Endoscopy on Air
  • Mauna Kea Technologies Extends Its Financial Horizon Beyond the Observation Period of the Safeguard Procedure 

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Cookie policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}